Sparrow Therapy System
FDA 510(k) K201873 · Spark Biomedical, Inc.
510(k) numberK201873
Submission
- Device name
- Sparrow Therapy System
- Applicant
- Spark Biomedical, Inc.
Dallas, TX, US - Received
- July 7, 2020
- Decision date
- January 2, 2021
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Other 510(k)s with product code PZR
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K251246 | Sparrow AscentPZR · Traditional | Spark Biomedical, Inc. | 08/25/2025SE |
| K233166 | NET Recovery Corp/NET DevicePZR · Traditional | Net Recovery | 05/29/2024SE |
| K230796 | Sparrow AscentPZR · Traditional | Spark Biomedical, Inc. | 06/20/2023SE |
| K221231 | Drug Relief v1PZR · Special | Dyansys, Inc. | 06/06/2022SE |
| K211971 | Drug Relief v1PZR · Traditional | Dyansys, Inc. | 11/05/2021SE |
| K173861 | Drug ReliefPZR · Traditional | Dyansys, Inc. | 05/02/2018SE |
More from Dyansys, Inc.
Questions and answers
When was Sparrow Therapy System cleared by the FDA?
Sparrow Therapy System (K201873) received a 510(k) decision of Substantially Equivalent on January 2, 2021, 179 days after the submission was received.
What is the product code of K201873?
The FDA product code is PZR – Percutaneous Nerve Stimulator For Opioid Withdrawal, a Class II (moderate risk) device regulated under 21 CFR 882.5896.